Gabor Cserni
Overview
Explore the profile of Gabor Cserni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
202
Citations
1674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bodi B, Vago R, Nagy L, Raduly A, Gulyas A, Kupecz K, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076880
Uremic cardiomyopathy, characterized by diastolic dysfunction, left ventricular hypertrophy (LVH), and fibrosis, is a common cardiovascular complication of chronic kidney disease (CKD). Men are at a higher risk for cardiovascular...
2.
Rakha E, Quinn C, Raymond W, Allison K, Badve S, Brogi E, et al.
Mod Pathol
. 2025 Feb;
38(5):100734.
PMID: 39947480
Fibroepithelial lesions (FELs) of the breast represent a diverse group of biphasic tumors with varying morphologies and clinical behavior. The classification of FELs is mainly based on a constellation of...
3.
Cserni G
Pathologica
. 2025 Jan;
116(5):273-284.
PMID: 39748709
Invasive lobular carcinoma of the breast is the most common special type breast cancer. It has been defined using morphological features, has a characteristic immunophenotype associated with the loss of...
4.
Zombori T, Ferenczi A, Sejben A, Almasi S, Szelestei V, Koszo R, et al.
Pathol Res Pract
. 2024 Nov;
265:155732.
PMID: 39580878
Histological grade is a validated prognostic factor of breast cancer but may show alterations following neoadjuvant chemotherapy (NACT). Its reporting after NACT is recommended by several guidelines, but evidence of...
5.
Karancsi Z, Gregus B, Krenacs T, Cserni G, Nagy A, Szocs-Trinfa K, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273393
Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis and limited treatment options. This study evaluates the prognostic value of stromal markers in TNBC, focusing...
6.
Rakha E, Quinn C, Masannat Y, Lee A, Tan P, Karakatsanis A, et al.
Eur J Surg Oncol
. 2024 Sep;
50(10):108573.
PMID: 39243583
Clinical trials have demonstrated conclusively the non-inferiority of breast-conserving surgery followed by breast radiation therapy (BCT) compared with mastectomy for the treatment of early-stage invasive breast cancer (BC). The definition...
7.
Pancsa T, Posfai B, Schubert A, Almasi S, Papp E, Chien Y, et al.
Virchows Arch
. 2024 Jun;
PMID: 38902365
Angiosarcoma (AS) of the breast, a rare mesenchymal neoplasm, exhibits distinct forms based on etiological and genetic features. While cases with typical clinical presentation and morphology allow for a straightforward...
8.
Cserni G, Bori R, Ambrozay E, Serfozo O
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730592
Invasive lobular carcinoma of the breast has different mammographic appearances, including spiculated or lobulated masses, architectural distortion, increased breast density, and the possibility of also being occult. Histologically, the morphology...
9.
Gronewold M, Grote I, Bartels S, Christgen H, Kandt L, Brito M, et al.
J Pathol Clin Res
. 2024 Apr;
10(2):e12361.
PMID: 38618992
Invasive lobular carcinoma (ILC) is a special breast cancer type characterized by noncohesive growth and E-cadherin loss. Focal activation of P-cadherin expression in tumor cells that are deficient for E-cadherin...
10.
Almasi S, Cserni G
Pathol Res Pract
. 2024 Apr;
257:155280.
PMID: 38608372
In breast conservative surgery, it is sometimes difficult to decide whether the cauterised tissue at the inked margin represents normal / hyperplastic or neoplastic tissue. We retrospectively assessed the value...